Skip to content
PIL Logo

Somatuline Autogel 60mg, Somatuline Autogel 90mg, Somatuline Autogel 120mg New device

Last Updated on eMC 12-Mar-2015 View document  | Ipsen Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12-Mar-2015 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 6 - date of revision
  • Change to section 1 - what the product is

Updated on 21-Nov-2012 and displayed until 12-Mar-2015

Reasons for adding or updating:

  • Change to date of revision
  • Change to side-effects

Updated on 05-Dec-2011 and displayed until 21-Nov-2012

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Ipsen Ltd

Company image

190 Bath Road, Slough, Berkshire, SL1 3XE


+44 (0)1753 627 778

Medical Information e-mail

+44 (0)1753 627 777

Medical Information Direct Line

+44 (0)1753 627 777

Customer Care direct line

+44 (0)1753 627 627

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

lanreotide acetate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue